Analyst IMS Investment Management Services Ltd.

Position in LLY — ELI LILLY & Co

CIK 1634208 Tel-aviv, L3

Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,455,233

-$53,899 QoQ

Shares Held

2,047

-25.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#2,309

of 4,605 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Analyst IMS Investment Management Services Ltd. holds $26,750,918 across 7 Drug Manufacturers - General names. LLY ranks #2 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	410,770	$19,692,313
2	LLY	ELI LILLY & Co This page	2,047	$2,455,233
3	JNJ	Johnson & Johnson	8,024	$2,037,854
4	MRK	Merck & Co., Inc.	8,995	$1,155,857
5	ABBV	AbbVie Inc.	3,869	$973,595
6	SNY	Sanofi	5,208	$222,173
7	GILD	Gilead Sciences, Inc.	1,693	$213,893

All Filings in LLY

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,455,233	2,047	-25.0%	Shares	Defined	2026-07-29
2026-03-31	$2,509,132	2,728	+7.4%	Shares	Defined	2026-04-23
2025-12-31	$2,730,762	2,541	+73.9%	Shares	Defined	2026-01-20
2025-09-30	$1,114,743	1,461	-13.6%	Shares	Defined	2025-10-20
2025-06-30	$1,317,405	1,690	-43.4%	Shares	Defined	2025-08-04
2025-03-31	$2,466,167	2,986	+69.9%	Shares	Defined	2025-04-21
2024-12-31	$1,357,176	1,758	-34.3%	Shares	Defined	2025-02-10
2024-09-30	$2,369,003	2,674	+68.3%	Shares	Defined	2024-11-12
2024-06-30	$1,438,648	1,589	+255.5%	Shares	Defined	2024-08-12
2024-03-31	$347,748	447	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.